{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:15Z","timestamp":1794047355358,"version":"4.8.0"},"reference-count":53,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"5","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>We have identified a rare missense variant on chromosome 9, position 125145990 (GRCh37), in exon 8 in PTGS1 (the gene encoding cyclo-oxygenase 1, COX-1, the target of anti-thrombotic aspirin therapy). We report that in the homozygous state within a large consanguineous family this variant is associated with a bleeding phenotype and alterations in platelet reactivity and eicosanoid production. Western blotting and confocal imaging demonstrated that COX-1 was absent in the platelets of three family members homozygous for the PTGS1 variant but present in their leukocytes. Platelet reactivity, as assessed by aggregometry, lumi-aggregometry and flow cytometry, was impaired in homozygous family members, as were platelet adhesion and spreading. The productions of COX-derived eicosanoids by stimulated platelets were greatly reduced but there were no changes in the levels of urinary metabolites of COX-derived eicosanoids. The proband exhibited additional defects in platelet aggregation and spreading which may explain why her bleeding phenotype was slightly more severe than those of other homozygous affected relatives. This is the first demonstration in humans of the specific loss of platelet COX-1 activity and provides insight into its consequences for platelet function and eicosanoid metabolism. Notably despite the absence of thromboxane A2 (TXA2) formation by platelets, urinary TXA2 metabolites were in the normal range indicating these cannot be assumed as markers of in vivo platelet function. Results from this study are important benchmarks for the effects of aspirin upon platelet COX-1, platelet function and eicosanoid production as they define selective platelet COX-1 ablation within humans.<\/jats:p>","DOI":"10.3324\/haematol.2019.235895","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T17:35:17Z","timestamp":1587058517000},"page":"1423-1432","source":"Crossref","is-referenced-by-count":13,"title":["Identification of a homozygous recessive variant in &lt;i&gt;PTGS1&lt;\/i&gt; resulting in a congenital aspirin-like defect in platelet function"],"prefix":"10.3324","volume":"106","author":[{"given":"Melissa V.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Hayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Suthesh Sivapalaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Marilena Crescente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet E.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Edin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl C.","family":"Zeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Jonathan Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Daniel Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Moghees Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie B.","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Liang Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Malkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Claire Lentaigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Katherine Wedderburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Matthew Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kate Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem H.","family":"Ouwehand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ernest Turro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"NIHR BioResource","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Kathleen Freson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Laffan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"key":"25264","doi-asserted-by":"crossref","unstructured":"Allen RD, Zacharski LR, Widirstky ST, Rosenstein R, Zaitlin LM, Burgess DR. Transformation and motility of human platelets. Details of the shape change and release reaction observed by optical and electron microscopy. J Cell Biol. 1979; 83(1):126-142.","DOI":"10.1083\/jcb.83.1.126"},{"key":"25265","doi-asserted-by":"crossref","unstructured":"Bearer EL, Prakash JM, Li Z. Actin dynamics in platelets. Int Rev Cytol. 2002; 217:137-182.","DOI":"10.1016\/S0074-7696(02)17014-8"},{"key":"25266","doi-asserted-by":"crossref","unstructured":"Brass LF, Wannemacher KM, Ma P, Stalker TJ. Regulating thrombus growth and stability to achieve an optimal response to injury. J Thromb Haemost. 2011; 9(1):66-75.","DOI":"10.1111\/j.1538-7836.2011.04364.x"},{"key":"25267","doi-asserted-by":"crossref","unstructured":"Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000; 69(1):145-182.","DOI":"10.1146\/annurev.biochem.69.1.145"},{"key":"25268","doi-asserted-by":"crossref","unstructured":"Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem. 1996; 271(52):33157-33160.","DOI":"10.1074\/jbc.271.52.33157"},{"key":"25269","doi-asserted-by":"crossref","unstructured":"Smith WL, Urade Y, Jakobsson PJ. Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chemical Rev. 2011; 111(10):5821-5865.","DOI":"10.1021\/cr2002992"},{"key":"25270","doi-asserted-by":"crossref","unstructured":"Ricciotti E, Fitzgerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31(5):986-1000.","DOI":"10.1161\/ATVBAHA.110.207449"},{"key":"25271","doi-asserted-by":"crossref","unstructured":"FitzGerald GA, Oates JA, Hawiger J. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 1983; 71(3):676-688.","DOI":"10.1172\/JCI110814"},{"key":"25272","doi-asserted-by":"crossref","unstructured":"Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest. 2004; 126(3):234S-264S.","DOI":"10.1378\/chest.126.3_suppl.234S"},{"key":"25273","doi-asserted-by":"crossref","unstructured":"Warner TD, Nylander S, Whatling C. Antiplatelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. Br J Clin Pharmacol. 2011; 72(4):619-633.","DOI":"10.1111\/j.1365-2125.2011.03943.x"},{"key":"25274","doi-asserted-by":"crossref","unstructured":"Jaffe EA, Weksler BB. Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. J Clin Invest. 1979; 63(3):532-535.","DOI":"10.1172\/JCI109332"},{"key":"25275","doi-asserted-by":"crossref","unstructured":"Westbury SK, Turro E, Greene D. Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders. Genome Med. 2015; 7(1):36.","DOI":"10.1186\/s13073-015-0151-5"},{"key":"25276","doi-asserted-by":"crossref","unstructured":"Ouwehand WH, Gr\u00e4f S, Tilly T, Swietlik EM, Morrell NW. Whole-genome sequencing of rare disease patients in a national healthcare system. BioRxiv. 2020.","DOI":"10.1101\/507244"},{"key":"25277","doi-asserted-by":"crossref","unstructured":"Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-5467.","DOI":"10.1073\/pnas.74.12.5463"},{"key":"25278","doi-asserted-by":"crossref","unstructured":"Vecchio AJ, Simmons DM, Malkowski MG. Structural basis of fatty acid substrate binding to cyclooxygenase-2. J Biol Chem. 2010; 285(29):22152-22163.","DOI":"10.1074\/jbc.M110.119867"},{"key":"25279","doi-asserted-by":"crossref","unstructured":"Mitchell JA, Knowles RB, Kirkby NS. Kidney transplantation in a patient lacking cytosolic phospholipase A2proves renal origins of urinary PGI-M and TX-M. Circ Res. 2018; 122(4):555-559.","DOI":"10.1161\/CIRCRESAHA.117.312144"},{"key":"25280","doi-asserted-by":"crossref","unstructured":"Chan M V., Armstrong PCJJ, Papalia F, Kirkby NS, Warner TD. Optical multichannel (optimul) platelet aggregometry in 96- well plates as an additional method of platelet reactivity testing. Platelets. 2011; 22(7):485-494.","DOI":"10.3109\/09537104.2011.592958"},{"key":"25281","doi-asserted-by":"crossref","unstructured":"Chan M V, Warner TD. Standardised optical multichannel (optimul) platelet aggregometry using high-speed shaking and fixed time point readings. Platelets. 2012; 23(5):404-408.","DOI":"10.3109\/09537104.2011.603066"},{"key":"25282","doi-asserted-by":"crossref","unstructured":"Inoue O, Suzuki-Inoue K, Dean WL, Frampton J, Watson SP. Integrin \u03b1 2 \u03b2 1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLC\u03b32. J Cell Biol. 2003; 160(5):769-780.","DOI":"10.1083\/jcb.200208043"},{"key":"25283","doi-asserted-by":"crossref","unstructured":"Kircher M, Witten DM, Jain P, O\u2019roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014; 46(3):310-315.","DOI":"10.1038\/ng.2892"},{"key":"25284","doi-asserted-by":"crossref","unstructured":"Lek M, Karczewski KJ, Minikel EV. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016; 536(7616):285-291.","DOI":"10.1038\/nature19057"},{"key":"25285","doi-asserted-by":"crossref","unstructured":"Roberts LJ, Sweetman BJ, Oates JA. Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem. 1981; 256(16):8384-8393.","DOI":"10.1016\/S0021-9258(19)68855-1"},{"key":"25286","doi-asserted-by":"crossref","unstructured":"McFadyen JD, Peter K. Platelet lipidomics and function: Joining the dots. Blood. 2018; 132(5):465-466.","DOI":"10.1182\/blood-2018-06-854950"},{"key":"25287","doi-asserted-by":"crossref","unstructured":"Cathcart M-C, Tamosiuniene R, Chen G. Cyclooxygenase-2-linked attenuation of hypoxia-induced pulmonary hypertension and intravascular thrombosis. J Pharmacol Exp Ther. 2008; 326(1):51-58.","DOI":"10.1124\/jpet.107.134221"},{"key":"25288","doi-asserted-by":"crossref","unstructured":"Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ. 2000; 321(7270):1183-1187.","DOI":"10.1136\/bmj.321.7270.1183"},{"key":"25289","doi-asserted-by":"crossref","unstructured":"Lands LC, Stanojevic S. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. Cochrane Database Syst Rev. 2016; 4(6):CD001505.","DOI":"10.1002\/14651858.CD001505.pub4"},{"key":"25290","unstructured":"Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol. 1996; 102:9-21."},{"key":"25291","doi-asserted-by":"crossref","unstructured":"Schubert S, Weyrich AS, Rowley JW. A tour through the transcriptional landscape of platelets. Blood. 2014; 124(4):493-502.","DOI":"10.1182\/blood-2014-04-512756"},{"key":"25292","doi-asserted-by":"crossref","unstructured":"Chan M V., Knowles RBMM, Lundberg MH. P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation. Br J Clin Pharmacol. 2016; 81(4):621-633.","DOI":"10.1111\/bcp.12826"},{"key":"25293","doi-asserted-by":"crossref","unstructured":"Gurbel PA, Bliden KP, DiChiara J. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation. 2007; 115(25):3156-3164.","DOI":"10.1161\/CIRCULATIONAHA.106.675587"},{"key":"25294","doi-asserted-by":"crossref","unstructured":"Lee CR, Bottone FG, Krahn JM. Identification and functional characterization of polymorphisms in human cyclooxygenase- 1 (PTGS1). Pharmacogenet Genomics. 2007; 17(2):145-160.","DOI":"10.1097\/01.fpc.0000236340.87540.e3"},{"key":"25295","doi-asserted-by":"crossref","unstructured":"Loftin CD, Tiano HF, Langenbach R. Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2. Prostaglandins Other Lipid Mediat. 2002; 68-69:177-185.","DOI":"10.1016\/S0090-6980(02)00028-X"},{"key":"25296","doi-asserted-by":"crossref","unstructured":"Paknikar AK, Eltzner B, K\u00f6ster S. Direct characterization of cytoskeletal reorganization during blood platelet spreading. Prog Biophys Mol Biol. 2019; 144:166-176.","DOI":"10.1016\/j.pbiomolbio.2018.05.001"},{"key":"25297","doi-asserted-by":"crossref","unstructured":"Hochman R, Clark J, Rolla A, Thomas S, Kaldany A, D\u2019elia JA. Bleeding in patients with infections: are antibiotics helping or hurting?. Arch Intern Med. 1982; 142(8):1440-1442.","DOI":"10.1001\/archinte.1982.00340210032005"},{"key":"25298","doi-asserted-by":"crossref","unstructured":"Harrison P, Mackie I, Mumford A. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol. 2011; 155(1):30-44.","DOI":"10.1111\/j.1365-2141.2011.08793.x"},{"key":"25299","doi-asserted-by":"crossref","unstructured":"Greene D, Richardson S, Turro E. A fast association test for identifying pathogenic variants involved in rare diseases. Am J Hum Genet. 2017; 101(1):104-114.","DOI":"10.1016\/j.ajhg.2017.05.015"},{"key":"25300","doi-asserted-by":"crossref","unstructured":"Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet\/erythroleukemia cell prostaglandin G\/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 1991; 5(9):2304-2312.","DOI":"10.1096\/fasebj.5.9.1907252"},{"key":"25301","doi-asserted-by":"crossref","unstructured":"Kirkby NS, Reed DM, Edin ML. Inherited human group IVA cytosolic phospholipase A2deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation. FASEB J. 2015; 29(11):4568-4578.","DOI":"10.1096\/fj.15-275065"},{"key":"25302","doi-asserted-by":"crossref","unstructured":"Matijevic-Aleksic N, Mcphedran P, Wu KK. Bleeding disorder due to platelet prostaglandin H synthase-1 (PGHS-1) deficiency. Br J Haematol. 1996; 92(1):212-217.","DOI":"10.1046\/j.1365-2141.1996.279813.x"},{"key":"25303","doi-asserted-by":"crossref","unstructured":"Grosser T, Naji A, FitzGerald GA. Urinary prostaglandin metabolites: an incomplete reckoning and a flush to judgment. Circ Res. 2018; 122(4):537-539.","DOI":"10.1161\/CIRCRESAHA.118.312616"},{"key":"25304","doi-asserted-by":"crossref","unstructured":"Strandvik B, Svensson E, Seyberth HW. Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins Leukot Essent Fat Acids. 1996; 55(6):419-425.","DOI":"10.1016\/S0952-3278(96)90125-8"},{"key":"25305","doi-asserted-by":"crossref","unstructured":"Ciabattoni G, Davi G, Collura M. In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med. 2000; 162(4 Pt 1):1195-1201.","DOI":"10.1164\/ajrccm.162.4.9911071"},{"key":"25306","doi-asserted-by":"crossref","unstructured":"Dub\u00e9 JN, Drouin J, Aminian M, Plant MH, Laneuville O. Characterization of a partial prostaglandin endoperoxide H synthase-1 deficiency in a patient with a bleeding disorder. Br J Haematol. 2001; 113(4):878-885.","DOI":"10.1046\/j.1365-2141.2001.02867.x"},{"key":"25307","doi-asserted-by":"crossref","unstructured":"Fuse I, Ootsuka T, Hattori A, Mito M, Shibata A. Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclooxygenase deficiency. Int J Hematol. 1996; 63(4):317-324.","DOI":"10.1016\/0925-5710(96)00454-9"},{"key":"25308","doi-asserted-by":"crossref","unstructured":"Horellou MH, Lecompte T, Lecrubier C. Familial and constitutional bleeding disorder due to platelet cyclo\u2010oxygenase defi ciency. Am J Hematol. 1983; 14(1):1-9.","DOI":"10.1002\/ajh.2830140102"},{"key":"25309","doi-asserted-by":"crossref","unstructured":"Lagarde M, Byron PA, Vargaftig BB, Dechavanne M. Impairment of platelet thromboxane A 2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclooxygenase. Br J Haematol. 1978; 38(2):251-266.","DOI":"10.1111\/j.1365-2141.1978.tb01041.x"},{"key":"25310","doi-asserted-by":"crossref","unstructured":"Malmsten C, Hamberg M, Svensson J, Samuelsson B. Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. Proc Natl Acad Sci. 1975; 72(4):1446-1450.","DOI":"10.1073\/pnas.72.4.1446"},{"key":"25311","doi-asserted-by":"crossref","unstructured":"Nyman D, Eriksson AW, Lehmann W, Blomb\u00e4ck M. Inherited defective platelet aggregation with arachidonate as the main expression of a defective metabolism of arachidonic acid. Thromb Res. 1979; 14(4\u20135):739-746.","DOI":"10.1016\/0049-3848(79)90129-4"},{"key":"25312","doi-asserted-by":"crossref","unstructured":"Pareti FI, Mannucci PM, D\u2019Angelo A, Smith JB, Sautebin L, Galli G. Congenital deficiency of thromboxane and prostacyclin. Lancet. 1980; 315(8174):898-901.","DOI":"10.1016\/S0140-6736(80)90837-5"},{"key":"25313","doi-asserted-by":"crossref","unstructured":"Nance D, Campbell RA, Rowley JW. Combined variants in factor VIII and prostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants. J Thromb Haemost. 2016; 14(11):2230-2240.","DOI":"10.1111\/jth.13500"},{"key":"25314","doi-asserted-by":"crossref","unstructured":"Lein\u00f8e E, Zetterberg E, Kinalis S. Application of whole-exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the \u00d6resund Region, Scandinavia. Br J Haematol. 2017; 179(2):308-322.","DOI":"10.1111\/bjh.14863"},{"key":"25315","doi-asserted-by":"crossref","unstructured":"Yagmur E, Weiskirchen R, Schedel A, Bugert P. PTGS1 compound heterozygosity impairs gene expression and platelet aggregation and is associated with severe bleeding complications. Thromb Haemost. 2013; 110(5):1083-1085.","DOI":"10.1160\/TH13-02-0110"},{"key":"25316","doi-asserted-by":"crossref","unstructured":"Bastida JM, Lozano ML, Benito R. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders. Haematologica. 2018; 103(1):148-162.","DOI":"10.3324\/haematol.2017.171132"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/9716\/70769","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9716\/70770","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9716\/70769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:56:48Z","timestamp":1794045408000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/9716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,4,30]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2019.235895","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}